Cargando…

Hepatocyte-specific deletion of Mettl3 promotes hepatocellular carcinoma in mice

Detalles Bibliográficos
Autores principales:	Liu, Chunhong, Li, Xinzhi, Yao, Zhicheng, Li, Xueying, Chen, Zheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Chongqing Medical University 2023
Materias:	Rapid Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10475669/ https://www.ncbi.nlm.nih.gov/pubmed/37671390 http://dx.doi.org/10.1016/j.gendis.2023.02.048

Ejemplares similares

Hepatocyte-specific Wtap deficiency promotes hepatocellular carcinoma by activating GRB2–ERK depending on downregulation of proteasome-related genes
por: Li, Xinzhi, et al.
Publicado: (2023)

METTL1 promotes colorectal cancer cell proliferation by attenuating CHEK2-induced G1/S phase arrest
por: Jiang, Houxiang, et al.
Publicado: (2023)

The Effects of Boron Neutron Capture Therapy on Liver Tumors and Normal Hepatocytes in Mice
por: Suzuki, Minoru, et al.
Publicado: (2000)

Downregulation of hepatic METTL3 contributes to APAP-induced liver injury in mice
por: Liu, Chunhong, et al.
Publicado: (2023)

ACTIVE PROLIFERATION OF MOUSE HEPATOCYTES IN PRIMARY CULTURE UNDER DEFINED CONDITIONS AS COMPARED TO RAT HEPATOCYTES
por: Sawada, Norimasa, et al.
Publicado: (1988)

Interruption of bile acid enterohepatic circulation inhibits glycogen synthesis and promotes hepatocellular carcinoma progression
por: Wang, Jiyan, et al.
Publicado: (2023)

Deletion of G protein-coupled receptor 116 enhances neutrophil function and aggravates lung injury in mice
por: Wang, Ting, et al.
Publicado: (2022)

In vitro Progression‐associated c‐H‐ras Activation in Neoplastic Hepatocyte Lines Established from SV40‐T Antigen Gene‐harboring Transgenic Mice
por: Li, Hong, et al.
Publicado: (1991)

Gga3 gene-deleted C57BL/6J mice have elevated fasting blood glucose levels
por: Zhang, Xiaohong, et al.
Publicado: (2023)

Contribution of Chromosome 9p21‐22 Deletion to the Progression of Human Renal Cell Carcinoma
por: Kinoshita, Hidefumi, et al.
Publicado: (1995)

The methyltransferase METTL3 negatively regulates nonalcoholic steatohepatitis (NASH) progression
por: Li, Xinzhi, et al.
Publicado: (2021)

Lymphopenia predicts reduced survival in canine hepatocellular carcinoma
por: Suarez-Rodriguez, Jose Israel, et al.
Publicado: (2023)

The landscape of UBE2S in hepatocellular carcinoma: Prognostic significance, immuno-oncology feature and drug response
por: Qiu, Lipeng, et al.
Publicado: (2022)

Analysis of METTL3 and METTL14 in hepatocellular carcinoma
por: Liu, Xiangxiang, et al.
Publicado: (2020)

Frequent Loss of Heterozygosity on Chromosomes 16 and 4 in Human Hepatocellular Carcinoma
por: Zhang, Wandong, et al.
Publicado: (1990)

Gene expression profiles contribute to robustly predicting prognosis in hepatocellular carcinoma
por: Liu, Long, et al.
Publicado: (2023)

Bid-overexpression regulates proliferation and phosphorylation of Akt and MAPKs in response to etoposide-induced DNA damage in hepatocellular carcinoma cells
por: Li, Yuanyue, et al.
Publicado: (2012)

Human Lung Cancer Cell Line Producing Hepatocyte Growth Factor/Scatter Factor
por: Yoshinaga, Yasuteru, et al.
Publicado: (1992)

Disturbance of the Cell Cycle with Colchicine Enhances the Growth Advantage of Diethylnitrosamine‐initiated Hepatocytes in Rats
por: Tsutsumi, Masahiro, et al.
Publicado: (1996)

Elevated Levels of Plasma Transforming Growth Factor‐β in Patients with Hepatocellular Carcinoma
por: Shirai, Yasuhiro, et al.
Publicado: (1992)

Transition of Antibody to Hepatitis C Virus from Chronic Hepatitis to Hepatocellular Carcinoma
por: Kiyosawa, Kendo, et al.
Publicado: (1990)

Infigratinib Mediates Vascular Normalization, Impairs Metastasis, and Improves Chemotherapy in Hepatocellular Carcinoma
por: Huynh, Hung, et al.
Publicado: (2019)

Phase Ib Study of Lenvatinib Plus Pembrolizumab in Patients With Unresectable Hepatocellular Carcinoma
por: Finn, Richard S., et al.
Publicado: (2020)

Genetic landscape and clinical significance of cuproptosis-related genes in liver hepatocellular carcinoma
por: Hu, Dingtao, et al.
Publicado: (2023)

Pan-cancer immunogenic death analysis identifies key roles of CXCR3 and CCL18 in hepatocellular carcinoma
por: Guo, Jia, et al.
Publicado: (2023)

Immunohistochemical Localization of Hepatocyte Growth Factor Protein in Pancreas Islet A‐Cells of Man and Rats
por: Tsuda, Hiroyuki, et al.
Publicado: (1992)

Expression of Transforming Growth Factor‐β1 mRNA in Human Hepatocellular Carcinoma
por: Ito, Nobuyuki, et al.
Publicado: (1990)

Sex hormone-binding globulin impedes hepatocellular carcinoma growth via MERTK regulation
por: Lee, Sang R., et al.
Publicado: (2021)

Autologous Fixed Tumor Vaccine: A Formulation with Cytokine‐microparticles for Protective Immunity against Recurrence of Human Hepatocellular Carcinoma
por: Peng, Bao Gang, et al.
Publicado: (2002)

Increased Prevalence of HTLV‐I Infection in Patients with Hepatocellular Carcinoma Associated with Hepatitis C Virus
por: Okayama, Akihiko, et al.
Publicado: (1995)

A comprehensive evolutionary and epidemiological characterization of insertion and deletion mutations in SARS-CoV-2 genomes
por: Liu, Xue, et al.
Publicado: (2021)

Low Incidence of Point Mutation of c‐Ki‐ras and N‐ras Oncogenes in Human Hepatocellular Carcinoma
por: Tsuda, Hitoshi, et al.
Publicado: (1989)

Shortened Telomere Length in Hepatocellular Carcinomas and Corresponding Background Liver Tissues of Patients Infected with Hepatitis Virus
por: Ohashi, Kazuo, et al.
Publicado: (1996)

Construction of a novel predictive model with seven metabolism-related genes for hepatocellular carcinoma by machine learning
por: Mou, Lisha, et al.
Publicado: (2023)

Differing Distribution of Hepatocyte Growth Factor‐positive Cells in the Liver of LEC Rats with Acute Hepatitis, Chronic Hepatitis and Hepatoma
por: Nakayama, Nobuaki, et al.
Publicado: (1995)

Acute liver injury induces expression of FGF23 in hepatocytes via orphan nuclear receptor ERRγ signaling
por: Jung, Yoon Seok, et al.
Publicado: (2022)

Insertion/Deletion Polymorphism and Other Restriction Fragment Length Polymorphisms in the MCC Gene
por: Miyoshi, Yasuo, et al.
Publicado: (1992)

Integrative multi-platform meta-analysis of hepatocellular carcinoma gene expression profiles for identifying prognostic and diagnostic biomarkers
por: Gholizadeh, Maryam, et al.
Publicado: (2022)

Identification of TP53 mutation-associated prognostic genes and investigation of the immune cell infiltration in patients with hepatocellular carcinoma
por: Yang, Qijun, et al.
Publicado: (2023)

Novel in-frame FLNB deletion causes Larsen syndrome in a three-generation pedigree
por: Hickey, Scott E., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_jrr92hrirfdlpeu5nci74pg4dk